Ames, IA · Founded 2021 · Privately Held (backing)
Developer of animal vaccines designed to accelerate treatments for the animal health industry. Genvax Technologies is based in Ames, IA and was founded in 2021. Its last reported valuation was $25 million in Aug 2022. It has raised $8.4 million across 2 recorded rounds; the latest was a $3.4 million seed round in Jun 2024.
Last reported valuation
$25.0M
Oct 2026
Priced at
—
Total raised
$8.4M
Last round
Seed Round
Jun 2024
Team — not yet on record
No current team members for Genvax Technologies are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Genvax Technologies with a free account
·The complete investor list: 11 names
·Watch Genvax Technologies: the Monday email on marks, rounds and moves
